EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Circular RNAs in tuberculosis and lung cancer

Sadia Jabeen, Niaz Ahmed, Faiqa Rashid, Nand Lal, Fanhui Kong, Yingmei Fu, Fengmin Zhang

Clinica Chimica Acta · 2024-07 · 561 · 119810

DOI: 10.1016/j.cca.2024.119810 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinica Chimica Acta, 2024-07. Verfasst von Sadia Jabeen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: RNA, Circular, Lung Neoplasms, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 134 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review signifies the role of circular RNAs (circRNAs) in tuberculosis (TB) and lung cancer (LC), focusing on pathogenesis, diagnosis, and treatment. CircRNAs, a newly discovered type of non-coding RNA, have emerged as key regulators of gene expression and promising biomarkers in various bodily fluids due to their stability. The current review discusses circRNA biogenesis, highlighting their RNase-R resistance due to their loop forming structure, making them effective biomarkers. It details their roles in gene regulation, including splicing, transcription control, and miRNA interactions, and their impact on cellular processes and diseases. For LC, the review identifies circRNA dysregulation affecting cell growth, motility, and survival, and their potential as therapeutic targets and biomarkers. In TB, it addresses circRNAs' influence on host anti-TB immune responses, proposing their use as early diagnostic markers. The paper also explores the interplay between TB and LC, emphasizing circRNAs as dual biosignatures, and the necessity for differential diagnosis. It concludes that no single circRNA biomarker is universally applicable for both TB and LC. Ultimately, the review highlights the pivotal role of circRNAs in TB and LC, encouraging further research in biomarker identification and therapeutic development concomitant for both diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularLung NeoplasmsTuberculosisHumans

Stichwörter der Autor:innen

Circular RNA (circRNA)Co-occurrenceDrug resistanceLung cancerNon-coding RNAPathogenesisTuberculosis (TB)

Substanzen

RNA, Circular

Autor:innen und Institutionen

  • Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin 150081, China.
  • Department of Bioinformatics And Biosciences, Capital University Of Science & Technology, Islamabad Expressway, Kahuta Road, Zone-V, Islamabad, Pakistan.
  • Department of Physiology, School of Biomedical Sciences, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, 150081, China.
  • Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin 150081, China. Electronic address: fuyingmei@hrbmu.edu.cn.
  • Department of Microbiology, Wu Lien Teh Institute, Harbin Medical University, Harbin 150081, China; Heilongjiang Key Laboratory of Immunity and Infection, Harbin 150081, China. Electronic address: fengminzhang@ems.hrbmu…

Zitieren

APA

Jabeen, S., Ahmed, N., Rashid, F., Lal, N., Kong, F., Fu, Y., & Zhang, F. (2024). Circular RNAs in tuberculosis and lung cancer. Clinica Chimica Acta, 561, 119810. https://doi.org/10.1016/j.cca.2024.119810

Vancouver

Jabeen S, Ahmed N, Rashid F, Lal N, Kong F, Fu Y, et al. Circular RNAs in tuberculosis and lung cancer. Clinica Chimica Acta. 2024;561:119810. doi:10.1016/j.cca.2024.119810

BibTeX
@article{Jabeen2024,
  author = {Jabeen, Sadia and Ahmed, Niaz and Rashid, Faiqa and Lal, Nand and Kong, Fanhui and Fu, Yingmei and Zhang, Fengmin},
  title = {Circular RNAs in tuberculosis and lung cancer},
  journal = {Clinica Chimica Acta},
  year = {2024},
  volume = {561},
  pages = {119810},
  doi = {10.1016/j.cca.2024.119810}
}
Kostenlos starten →